In cohorts of individuals with chronic hepatitis C, elevated sMICA levels, functioned as the ADAM9 substrate, following viral clearance were associated with HCC progression as a means to evade NK-mediated immune surveillance (38, 39). The gene discussed is ADAM9; the disease is hepatocellular carcinoma.